Wako Distributing Cellectis Products in Japan | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French genomic engineering firm Cellectis said on Wednesday it has appointed Wako Pure Chemical Industries as its exclusive distributor in Japan.

Wako will handle sales of Cellectis' products including its Talen Access service, launched in February. In a statement, Luc Selig, vice president of sales and marketing for Cellectis, said that the company is targeting global distribution of Talen, which is a tool for specifically modifying genes in any type of cell.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.